Zucchi, Elisabetta
 Distribuzione geografica
Continente #
NA - Nord America 1.391
EU - Europa 651
AS - Asia 186
SA - Sud America 2
OC - Oceania 1
Totale 2.231
Nazione #
US - Stati Uniti d'America 1.385
IT - Italia 255
SE - Svezia 104
HK - Hong Kong 98
GB - Regno Unito 82
CN - Cina 63
DE - Germania 54
FI - Finlandia 32
FR - Francia 29
LT - Lituania 28
BG - Bulgaria 24
IE - Irlanda 12
ES - Italia 7
NL - Olanda 6
UA - Ucraina 6
VN - Vietnam 6
IN - India 5
RO - Romania 5
CA - Canada 4
MY - Malesia 4
CZ - Repubblica Ceca 3
TR - Turchia 3
BZ - Belize 2
GR - Grecia 2
IR - Iran 2
OM - Oman 2
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
JP - Giappone 1
KR - Corea 1
PT - Portogallo 1
SG - Singapore 1
Totale 2.231
Città #
Fairfield 254
Chandler 208
Ashburn 116
Hong Kong 98
Woodbridge 90
Nyköping 88
Seattle 78
Houston 77
Cambridge 69
Wilmington 68
Southend 51
Modena 37
San Diego 35
Helsinki 32
Ann Arbor 31
Beijing 29
Dearborn 28
Sofia 24
Milan 23
Princeton 22
Bremen 20
New York 20
Bologna 19
Shanghai 17
London 13
Jacksonville 12
Rome 12
Eugene 8
Los Angeles 7
Norwalk 7
Calcinaia 6
Amsterdam 5
Dong Ket 5
Fremont 5
Kilburn 5
Parma 5
Redwood City 5
Reggio Emilia 5
Valencia 5
Carpi 4
Des Moines 4
Dublin 4
Fidenza 4
Frankfurt am Main 4
Rimini 4
Bari 3
Bergamo 3
Brno 3
Buzau 3
Florence 3
Haddonfield 3
Izmir 3
Palo Del Colle 3
Sassuolo 3
Taranto 3
Belize City 2
Cesena 2
Chicago 2
Cutrofiano 2
Felino 2
Hounslow 2
Incisa 2
Leawood 2
Montpellier 2
Munich 2
Muscat 2
Occhiobello 2
Ottawa 2
Poggio Renatico 2
San Jose 2
Soliera 2
Tione di Trento 2
Toronto 2
Trapani 2
Travo 2
Trento 2
Turin 2
Albuquerque 1
Ardabil 1
Atlanta 1
Bad Bellingen 1
Bamberg 1
Boardman 1
Bolotana 1
Brentford 1
Bucharest 1
Castellammare Di Stabia 1
Castellammare di Stabia 1
Castelnuovo Rangone 1
Chemnitz 1
Clearwater 1
Desio 1
Ergolding 1
Falkenstein 1
Frattaminore 1
Fuzhou 1
Garden City 1
Genoa 1
Guangzhou 1
Hanoi 1
Totale 1.760
Nome #
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy 195
High‐frequency motor rehabilitation in amyotrophic lateral sclerosis: a randomized clinical trial 177
Post-infectious sensory neuropathy with anti-GT1a and GQ1b antibodies associated with cold urticaria 170
Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study 160
Pearls & Oy-sters: Paroxysmal dysarthria-ataxia syndrome: Acoustic analysis in a case of antiphospholipid syndrome 143
Proteostasis and ALS: Protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS) 142
Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 139
Environmental and Occupational Risk Factors of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study 138
Reply to comment on “environmental and occupational risk factors of amyotrophic lateral sclerosis: A population-based case-control study” 94
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 83
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy 83
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 75
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: A multicentre Italian study 73
Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers 72
Duplication of exons 15 and 16 in Matrin-3: a phenotype bridging amyotrophic lateral sclerosis and immune-mediated disorders 65
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study. 60
The gut microbiota-immunity axis in als: A role in deciphering disease heterogeneity? 58
CSF Heavy Neurofilament May Discriminate and Predict Motor Neuron Diseases with Upper Motor Neuron Involvement 53
A novel p.N66T mutation in exon 3 of the SOD1 gene: report of two families of ALS patients with early cognitive impairment 52
Psychiatric Symptoms in Amyotrophic Lateral Sclerosis: Beyond a Motor Neuron Disorder 46
Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype 28
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study 28
Insight into Elderly ALS Patients in the Emilia Romagna Region: Epidemiological and Clinical Features of Late-Onset ALS in a Prospective, Population-Based Study 25
G507D mutation in FUS gene causes familial amyotrophic lateral sclerosis with a specific genotype-phenotype correlation. 23
Factors predicting disease progression in C9ORF72 ALS patients 21
Young Onset Alzheimer’s Disease Associated with C9ORF72 Hexanucleotide Expansion: Further Evidence for a Still Unsolved Association 16
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 14
A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report 12
Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries 11
The landscape of cognitive impairment in superoxide dismutase 1-amyotrophic lateral sclerosis 10
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study 10
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 6
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 6
Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis 4
Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules 4
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 4
The association between lifelong personality and clinical phenotype in the FTD-ALS spectrum 2
Totale 2.302
Categoria #
all - tutte 14.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 0 26 41
2019/2020328 16 14 8 22 24 48 58 38 35 28 20 17
2020/2021404 31 19 22 32 66 32 25 37 32 51 33 24
2021/2022453 40 32 19 13 11 23 13 14 73 50 104 61
2022/2023553 63 71 29 51 67 73 9 54 64 15 27 30
2023/2024456 11 15 36 44 69 30 83 65 13 38 52 0
Totale 2.302